Last updated: April 23, 2026
Who supplies tolvaptan API and intermediates?
Tolvaptan is a small-molecule vasopressin V2 receptor antagonist. The supplier set typically breaks into three groups: API manufacturers, contract manufacturers for drug product, and intermediate/grade-chemical suppliers feeding API production. Market access depends on whether you need R&D grade, commercial API, or GMP drug product.
Common supplier archetypes in the tolvaptan supply chain
- API manufacturers (commercial scale, GMP): Provide tolvaptan API under DMF/CEP or equivalent regulatory packages.
- API intermediates suppliers: Provide key intermediates used in tolvaptan synthesis routes (often supplied under controlled change processes).
- Finished-dose CMOs: Manufacture tablets under GMP with sourcing for tolvaptan API and excipients handled either in-house or via qualified vendors.
Which finished-dose branded products drive the downstream supplier network?
Tolvaptan’s major global downstream anchors determine who qualifies as upstream supply. Key reference product:
- Samsca (tolvaptan): European and US market reference for the drug substance and drug product qualification pathways.
The presence of a reference product typically correlates with:
- Long-term qualified API suppliers
- Local CMO qualification for tablet manufacture, packaging, and batch release
- Regulatory alignment around polymorph, impurities, residual solvents, and particle attributes (if specified by the approved dossier)
What are the typical GMP supply requirements for tolvaptan?
Tolvaptan suppliers that serve commercial and regulated markets generally align with:
- GMP API: CoA per batch, impurity and residual solvent reporting, control strategy tied to the approved specification
- DMF/CEP support: To enable dossier referencing by downstream marketing authorizations
- Drug product manufacturing: Tablet/commercial packaging under GMP with full traceability and stability data
Key specification themes used by pharmaceutical buyers (applies to API and drug product procurement):
- Identity: validated analytical methods and reference standards
- Assay and potency: validated HPLC methods
- Impurities: specified limits tied to toxicological qualification
- Residual solvents: ICH Q3C-aligned limits
- Polymorph control: where dossier/analytical methods require it
- Particle size and solid-state properties: if specified for bioavailability-relevant performance
Which suppliers typically matter for tolvaptan procurement?
A practical procurement list must include at least:
- Tolvaptan API supplier (GMP)
- Drug product CMO (if you need tablets packaged and released)
- Analytical testing lab partner (if you need independent release or method transfer)
However, naming specific company suppliers requires authoritative, source-backed evidence (e.g., regulatory listings, DMF holders, CEP holders, or verified commercial catalogs with batch-level claims). The provided input does not include such source records.
Because accurate supplier identification without citation would risk misattribution, no supplier names are provided.
How do buyers qualify tolvaptan suppliers?
For tolvaptan, qualifying suppliers typically hinges on dossier-grade evidence and manufacturing controls. The qualification package most commonly includes:
- GMP certificate for manufacturing site
- DMF or CEP registration (where applicable)
- Full CoA dataset across representative batches
- Stability protocol and data where the supplier offers “API for formulation”
- Change control commitments for process, equipment, analytical method, and sourcing
Commercial buyers usually require:
- Compliance history for batch deviations (if any)
- Impurity profiling and trend reporting
- Residual solvent compliance
- Shipping and storage qualification (temperature/humidity controls)
Procurement channels that work for tolvaptan
API sourcing routes
- Direct from the DMF/CEP holder for clean regulatory referencing
- Via a distributor only when the distributor provides verified GMP/CoA traceability tied to the original manufacturer
- Via a toll manufacturer if you need an accelerated changeover timeline (requires tight oversight of the underlying API site)
Drug product sourcing routes
- Direct CMO with tolvaptan API sourced from a qualified upstream
- Integrated package (API plus drug product) where the CMO handles full technical transfer and stability program execution
What deliverables should you require from a tolvaptan supplier?
For RFP-grade procurement, the deliverables package typically includes:
- API specification (assay, impurities, residual solvents)
- Analytical methods or method summaries
- Reference standard traceability
- Batch manufacturing record-level summary (at least deviation summary)
- Release CoA templates and a sample CoA set
- Stability commitments for API and, if applicable, drug product intermediates and final tablets
Key Takeaways
- Tolvaptan procurement usually requires GMP API sourcing plus dossier-grade regulatory support (DMF/CEP or equivalent).
- Finished-dose qualification depends on tablet manufacturing and packaging GMP with traceable sourcing of tolvaptan API.
- Specific supplier names cannot be listed without source-backed evidence tied to regulated listings, DMF/CEP status, or verified commercial supply claims.
FAQs
-
Is tolvaptan typically sourced as GMP API or through drug product CMOs?
Most regulated commercialization relies on GMP API first, with drug product manufacturing done by a qualified CMO if tablets are needed.
-
What regulatory documentation do buyers request for tolvaptan API?
Buyers typically request GMP certificates and dossier support such as DMF/CEP and representative batch CoAs.
-
What controls matter most in tolvaptan API quality?
Buyers focus on assay, impurities, residual solvents, and any solid-state/polymorph controls specified in the approved specification.
-
Can distributors supply tolvaptan API for commercial dossiers?
Yes in some cases, but only if the distributor provides validated traceability to the underlying manufacturer and batch-level CoA documentation tied to the correct site.
-
Does tolvaptan supplier qualification include stability data?
Yes. For API-to-drug product development and commercial readiness, buyers typically require stability commitments and data relevant to storage conditions and shelf-life.
References
[1] Not provided.
